Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Assay Genie supplies over 120,000 life science reagents—including antibodies (monoclonal/polyclonal/therapeutic/biosimilar), ELISA kits & pairs (including high-sensitivity cytokine panels and hormone assays), recombinant proteins, multiplex immunoassays ("GeniePlex"), mycoplasma detection kits ("GenieColor"), cell viability/cytotoxicity/metabolism assays. Their products are widely cited in peer-reviewed journals and trusted by leading academic institutions and pharmaceutical companies globally. They also offer extensive custom service capabilities to design bespoke antibodies/proteins/ELISAs/multiplex panels/cell lines to meet specific R&D needs. The company has grown rapidly since its founding in Ireland in March 2017 with global distribution to over seventy countries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Assay Genie.